TLP
MYOV

Tri Locum Partners’s Myovant Sciences Ltd. MYOV Stock Holding History

Tri Locum Partners’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-321,101
Closed -$6.61M – 43
2021
Q1 		$6.61M Buy
321,101
+280,191
+685% +$6.38M 1.64% 17
2020
Q4 		$1.13M Buy
+40,910
New +$796K 0.41% 35

Other funds holding MYOV

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Tri Locum Partners's MYOV Position: Q2 2021 in Review

Tri Locum Partners sold out of Myovant Sciences Ltd. (MYOV) in Q2 2021, closing a stake of 321,101 shares — an estimated $6.61M sold.

Tri Locum Partners first reported a position in MYOV in Q4 2020 and held it in 2 quarters. The position peaked at $6.61M in Q1 2021. 108 funds tracked by Wall St. Rank hold MYOV as of Q2 2021.

  • Tri Locum Partners reported no remaining Myovant Sciences Ltd. position as of Q2 2021 after selling out during the quarter.
  • Tri Locum Partners sold 321,101 Myovant Sciences Ltd. shares in Q2 2021, an estimated $6.61M.
  • Tri Locum Partners first reported a position in Myovant Sciences Ltd. in Q4 2020 and held it in 2 quarters.
  • Tri Locum Partners's Myovant Sciences Ltd. position peaked at $6.61M in Q1 2021.
  • 108 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q2 2021.

Based on Tri Locum Partners's 13F filing for Q2 2021, filed 16 Aug 2021.